NL165652B - Werkwijze ter bereiding van een preparaat met anti- trombosewerking en/of diagnosticum voor trombine in bloed op basis van l-argininederivaten, het gevormde preparaat, het gevormde diagnosticum en werkwijze ter bereiding van l-argininederivaten. - Google Patents

Werkwijze ter bereiding van een preparaat met anti- trombosewerking en/of diagnosticum voor trombine in bloed op basis van l-argininederivaten, het gevormde preparaat, het gevormde diagnosticum en werkwijze ter bereiding van l-argininederivaten.

Info

Publication number
NL165652B
NL165652B NL7410647.A NL7410647A NL165652B NL 165652 B NL165652 B NL 165652B NL 7410647 A NL7410647 A NL 7410647A NL 165652 B NL165652 B NL 165652B
Authority
NL
Netherlands
Prior art keywords
preparation
prepared
diagnostic
thrombine
blood
Prior art date
Application number
NL7410647.A
Other languages
English (en)
Other versions
NL165652C (nl
NL7410647A (nl
Inventor
Ryoji Kikumoto
Shinji Tonomura
Kazuo Ohkubo
Original Assignee
Mitsubishi Chem Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP9069973A external-priority patent/JPS5521742B2/ja
Priority claimed from JP11603573A external-priority patent/JPS5521743B2/ja
Priority claimed from JP11729273A external-priority patent/JPS5521744B2/ja
Priority claimed from JP13750173A external-priority patent/JPS5521745B2/ja
Priority claimed from JP3114174A external-priority patent/JPS5542073B2/ja
Priority claimed from JP3326074A external-priority patent/JPS5521746B2/ja
Priority claimed from JP6157374A external-priority patent/JPS5542074B2/ja
Application filed by Mitsubishi Chem Ind filed Critical Mitsubishi Chem Ind
Publication of NL7410647A publication Critical patent/NL7410647A/nl
Publication of NL165652B publication Critical patent/NL165652B/nl
Application granted granted Critical
Publication of NL165652C publication Critical patent/NL165652C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)
NL7410647.A 1973-08-13 1974-08-08 Werkwijze ter bereiding van een preparaat met anti- trombosewerking en/of diagnosticum voor trombine in bloed op basis van l-argininederivaten, het gevormde preparaat, het gevormde diagnosticum en werkwijze ter bereiding van l-argininederivaten. NL165652C (nl)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP9069973A JPS5521742B2 (nl) 1973-08-13 1973-08-13
JP11603573A JPS5521743B2 (nl) 1973-10-16 1973-10-16
JP11729273A JPS5521744B2 (nl) 1973-10-18 1973-10-18
JP13750173A JPS5521745B2 (nl) 1973-12-10 1973-12-10
JP3114174A JPS5542073B2 (nl) 1974-03-19 1974-03-19
JP3326074A JPS5521746B2 (nl) 1974-03-25 1974-03-25
JP6157374A JPS5542074B2 (nl) 1974-05-31 1974-05-31

Publications (3)

Publication Number Publication Date
NL7410647A NL7410647A (nl) 1975-02-17
NL165652B true NL165652B (nl) 1980-12-15
NL165652C NL165652C (nl) 1981-05-15

Family

ID=27564271

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7410647.A NL165652C (nl) 1973-08-13 1974-08-08 Werkwijze ter bereiding van een preparaat met anti- trombosewerking en/of diagnosticum voor trombine in bloed op basis van l-argininederivaten, het gevormde preparaat, het gevormde diagnosticum en werkwijze ter bereiding van l-argininederivaten.

Country Status (9)

Country Link
US (1) US4670420A (nl)
CA (1) CA1029026A (nl)
CH (4) CH612929A5 (nl)
DE (1) DE2438851C2 (nl)
DK (1) DK140431B (nl)
FR (1) FR2240720B1 (nl)
GB (1) GB1475346A (nl)
NL (1) NL165652C (nl)
NO (1) NO140344C (nl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7512637A (nl) * 1974-11-08 1976-05-11 Mitsubishi Chem Ind Werkwijze ter bereiding van een geneesmiddel, het aldus gevormde geneesmiddel en werkwijze voor de bereiding van actieve component.
CA1102316A (en) * 1975-12-09 1981-06-02 Shosuke Okamoto N su2 xx-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
FR2378004B2 (fr) * 1975-12-09 1985-09-13 Mitsubishi Chem Ind Derives de l'argininamide, leur preparation et leurs utilisations therapeutiques
EP0190852A3 (en) * 1985-01-31 1988-11-02 Ajinomoto Co., Inc. Dipeptide derivatives and antihypertensive drugs containing them
JP4010951B2 (ja) * 2001-05-15 2007-11-21 大正製薬株式会社 アルギニン誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE420919B (sv) * 1973-08-13 1981-11-09 Mitsubishi Chem Ind Forfarande for framstellning av n?722-dansyl-l-argininderivat och farmaceutiskt godtagbara syradditionssalter derav
US4069329A (en) * 1974-11-08 1978-01-17 Mitsubishi Chemical Industries Limited N2 -Naphthalenesulfonyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof
US4072744A (en) * 1974-11-08 1978-02-07 Mitsubishi Chemical Industries Limited N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4069317A (en) * 1974-11-08 1978-01-17 Mitsubishi Chemical Industries Ltd. N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4072743A (en) * 1974-11-08 1978-02-07 Mitsubishi Chemical Industries Limited N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof

Also Published As

Publication number Publication date
DK140431B (da) 1979-08-27
DK140431C (nl) 1980-01-28
CH612929A5 (nl) 1979-08-31
CH613945A5 (nl) 1979-10-31
CH613946A5 (nl) 1979-10-31
NL165652C (nl) 1981-05-15
FR2240720B1 (nl) 1978-07-21
GB1475346A (en) 1977-06-01
CA1029026A (en) 1978-04-04
DE2438851A1 (de) 1975-02-27
NO140344C (no) 1979-08-15
NO742886L (nl) 1975-03-10
CH612928A5 (nl) 1979-08-31
DE2438851C2 (de) 1987-03-19
US4670420A (en) 1987-06-02
DK429474A (nl) 1975-04-21
NO140344B (no) 1979-05-07
FR2240720A1 (nl) 1975-03-14
NL7410647A (nl) 1975-02-17

Similar Documents

Publication Publication Date Title
NL7607338A (nl) Werkwijze voor de bereiding van 1,4-dihydro- pyrinederivaten met vaatverwijdende en bloed- drukverlagende activiteit.
NL7503754A (nl) Werkwijze voor de bereiding van anilidederiva- ten, alsmede met toepassing hiervan bereide microbicide preparaten.
NL178650B (nl) Werkwijze ter bereiding van samenstellingen voor menselijke consumptie of cosmetisch gebruik op basis van een mentholester, alsmede werkwijze ter bereiding van deze mentholesters.
NL182369C (nl) Werkwijze voor het bereiden van een oraal geneesmiddelpreparaat met verlengde afgifte.
NL7514940A (nl) Werkwijze voor het bereiden van azolyl-1 methanen en de zouten daarvan, alsmede de toe- passing daarvan als geneesmiddelen.
NL168518C (nl) Werkwijze ter bereiding of vervaardiging van een farmaceutisch preparaat met immunologische activiteit, alsmede werkwijze ter bereiding van een 1.3-propaan-diol-3-fosforylethanolamine-derivaat, geschikt voor gebruik bij de voornoemde werkwijze.
NL177747C (nl) Werkwijze voor het bereiden van farmaceutische preparaten met een anti-trombose-werking alsmede werkwijze voor het bereiden van voor toepassing in dergelijke preparaten bruikbare nŸ2-arylsulfonyl-l-argininederivaten.
NL166939C (nl) Werkwijze voor het bereiden van geneesmiddelen met een gunstige invloed op de bloedsomloop, alsmede werkwijze voor het bereiden van daarvoor geschikte actieve verbindingen.
NL7412935A (nl) Werkwijze voor het bereiden van een antista- makend en weefsel verzachtend preparaat.
NL7701909A (nl) Werkwijze voor de bereiding van een geneesmiddel tegen kanker, werkwijze voor de bereiding van de actieve component en het bereide geneesmiddel.
FI52720C (fi) Menetelmä veren sokeripitoisuutta alentavien pyratsiinijohdannaisten v almistamiseksi.
NL7409344A (nl) Werkwijze voor het bereiden van alkoxyalkyl 1.4-dihydropyridinen, alsmede de toepassing daarvan als farmaceutische preparaten.
NL164203C (nl) Werkwijze voor het bereiden van bevroren mensenbloed of een etythrocyten-bevattende fractie daarvan bij aanwezigheid van een cryofylacticum.
NL181552C (nl) Werkwijze voor de bereiding of vervaardiging van farmaceutische preparaten met prostaglandine-achtige eigenschappen, aldus bereid of vervaardigd gevormd preparaat alsmede werkwijze voor de bereiding van hiervoor geschikte hepteenzuurderivaten.
NL159562B (nl) Werkwijze voor het bereiden van een insekticide preparaat en het aldus bereide preparaat.
NL7513524A (nl) Werkwijze voor het bereiden van furanhydroxam- zuurderivaten, werkwijze voor het bereiden van fungicide preparaten met deze derivaten, alsme- de de gevormde preparaten.
NL162377C (nl) Werkwijze voor het bereiden van tegen protozoen actieve geneesmiddelen, onder toepassing daarvan verkregen gevormde geneesmiddelen, alsmede werkwijze voor het bereiden van daardoor geschikte, actieve stoffen.
NL7415815A (nl) Werkwijze voor het bereiden van pyrimidine- thionothiolfosforzuuresters, alsmede de toe- passing daarvan als insecticiden en acariciden.
NL165652C (nl) Werkwijze ter bereiding van een preparaat met anti- trombosewerking en/of diagnosticum voor trombine in bloed op basis van l-argininederivaten, het gevormde preparaat, het gevormde diagnosticum en werkwijze ter bereiding van l-argininederivaten.
NL180021C (nl) Werkwijze voor de bereiding van beta-amylase en alfa-1,6-glucosidase.
NL163707C (nl) Werkwijze voor het bereiden van een insekticide- en acaricide-preparaat.
NL163514C (nl) Werkwijze voor het bereiden van een preparaat met anti- -allergische werking op basis van 1-oxo-1h-pyrimidoŸ1,2-aŸ chinoline-2-carbonzuurderivaten en werkwijze ter bereiding van een geneeskrachtige verbinding, geschikt voor gebruik bij de bereiding van genoemd preparaat.
NL7412254A (nl) Werkwijze voor het bereiden van een oraal pre- paraat tegen diabetes.
NL7415594A (nl) Werkwijze ter bereiding van verbindingen met bepaalde geur- en aroma-eigenschappen, alsmede voor het toepassen daarvan en de onder toepas- sing van deze verbindingen verkregen producten.
NL176257B (nl) Werkwijze voor het bereiden van diakylaminomethylbenzamideverbindingen, alsmede voor het bereiden en/of vormen van een preparaat met anti-viruswerking.

Legal Events

Date Code Title Description
BK Erratum

Free format text: IE NR,12V,80:UITVINDERS MOET ZIJN RYOJI KIKUMOTO TE TOKYO,YOSHIKUNI TAMAO TE YOKOHAMA ENZ.

V1 Lapsed because of non-payment of the annual fee